Patent for non-PFAS inner diameter coating

Biocoat Inc. received issuance of a patent for "Lumen Coating Method and Apparatus,” covering groundbreaking thermal cure hydrophilic coating technology specifically designed for application to the lumen, or inner diameter. This technology is commonly applied in catheters and other medical devices used in multiple medical specialties, including cardiology and neurology.

The patented technology represents a significant advancement in medical device coatings, offering the industry a high-performance, non-per- and polyfluoroalkyl substances (PFAS) alternative. As concerns over the environmental and health impacts of PFAS continue to grow, Biocoat's innovation provides a safer, more sustainable solution for medical device manufacturers without compromising on quality or performance.

"This patent is a testament to Biocoat's commitment to developing innovative and responsible technologies that address the evolving needs of the medical device industry," says Jim Moran, president and CEO at Biocoat Incorporated. "Our unique, hydrophilic, non-PFAS coating technology is a game-changer for devices that require the coating of internal surfaces like catheter lumens. This innovation will give medical device manufacturers coating options that align with global efforts to reduce reliance on PFAS materials."

"The new coating technology delivers excellent lubricity, durability, and low particulate counts, all while utilizing lower curing temperatures such that common polymer substrates are not impacted. This coating technology has proven itself over 30+ years and has been used on hundreds of 510k approved products. By offering a hydrophilic, non-PFAS option, we're supporting the industry's shift towards greener and more environmentally friendly materials, contributing to the development of safer medical products for patients worldwide," says Bob Hergenrother, VP of Research, Development & Innovation at Biocoat.